Rachelle Doody

Doody holds a B.A. in English in 1978 and M.A./Ph.D. in Cognitive Anthropology in 1992 from Rice University.{{Cite web |title=Past Laureates Honorees |url=https://alumni.rice.edu/laureates/past-laureates-honorees |access-date=2022-09-29 |website=The Association of Rice Alumni {{!}} Rice University |language=en}} She did her medical training at Baylor College of Medicine in Houston, Texas, obtaining her M.D. in 1983.{{Cite web |title=Baylor College of Medicine Award recipients |url=https://cdn.bcm.edu/sites/default/files/past-alumni-award-recipients.pdf |access-date=October 24, 2022}} After medical school, Doody took a year of internship in internal medicine at McGill University in Montreal, Canada and then returned to Baylor College of Medicine in Houston she did a residency in Neurology, finishing in 1987. Upon finishing her residency, she began a Ph.D. which she would complete in 1992.{{Cite journal |last=Williams |first=Ruth |date=2011 |title=Rachelle Doody: an appetite for variety |url=https://doi.org/10.1016/S1474-4422(10)70317-3 |journal=The Lancet Neurology |volume=10 |issue=1 |pages=28 |doi=10.1016/s1474-4422(10)70317-3 |issn=1474-4422 |pmid=21163443 |s2cid=42590673}} At Baylor College of Medicine Doody founded and directed the Alzheimer’s Disease and Memory Disorders Center, was the Effie Marie Cain Chair in Alzheimer’s Disease Research and, as of 2022, she is Distinguished Professor Emeritus.{{Cite web |title=Rachelle Doody |url=https://www.bcm.edu/people-search/rachelle-doody-20658 |access-date=2022-09-29 |website=Baylor College of Medicine |language=en}} In 2016 she moved to Genentech / Roche where she is the Vice President, Global Head of Neurodegeneration and the Alzheimer's disease and Neurodegeneration Franchise Head in Product Development, Neuroscience at Roche Pharmaceutical Company and its US entity, Genentech.

Doody is primarily known for her work on the diagnosis and treatment of Alzheimer’s disease and related neurodegenerative disorders. For her Ph.D. she worked on cognitive anthropology, which included studying cognition among non-literate Karen hill tribes in Northern Thailand. Some of her early research was on alien hand syndrome{{Cite journal |last1=Doody |first1=R S |last2=Jankovic |first2=J |date=1992-09-01 |title=The alien hand and related signs. |journal=Journal of Neurology, Neurosurgery & Psychiatry |language=en |volume=55 |issue=9 |pages=806–810 |doi=10.1136/jnnp.55.9.806 |issn=0022-3050 |pmc=1015106 |pmid=1402972}} where she worked to understand the condition in the brain with people exhibiting the condition.{{Cite news |last=Mough |first=Thomas H. |date=1991-04-25 |title=Researchers attempt to pinpoint 'alien hand syndrome' |pages=372 |work=The Los Angeles Times |url=https://www.newspapers.com/clip/110384996/researchers-attempt-to-pinpoint-alien/ |access-date=2022-09-29}} Doody led the phase 2 and 3 development of donepezil, a medication for dementia, and has worked to broaden the diagnosis and treatment of Alzheimer's disease.

• {{Cite journal |last1=Doody |first1=R S |last2=Jankovic |first2=J |date=1992-09-01 |title=The alien hand and related signs. |journal=Journal of Neurology, Neurosurgery & Psychiatry |language=en |volume=55 |issue=9 |pages=806–810 |doi=10.1136/jnnp.55.9.806 |issn=0022-3050 |pmc=1015106 |pmid=1402972}}
• {{Cite journal |last1=Petersen |first1=Ronald C. |last2=Doody |first2=Rachelle |last3=Kurz |first3=Alexander |last4=Mohs |first4=Richard C. |last5=Morris |first5=John C. |last6=Rabins |first6=Peter V. |last7=Ritchie |first7=Karen |last8=Rossor |first8=Martin |last9=Thal |first9=Leon |last10=Winblad |first10=Bengt |date=2001-12-01 |title=Current Concepts in Mild Cognitive Impairment |url=http://archneur.jamanetwork.com/article.aspx?doi=10.1001/archneur.58.12.1985 |journal=Archives of Neurology |language=en |volume=58 |issue=12 |pages=1985–1992 |doi=10.1001/archneur.58.12.1985 |pmid=11735772 |issn=0003-9942}}
• {{Cite journal |last1=Doody |first1=R. S. |last2=Stevens |first2=J.C. |last3=Beck |first3=C. |last4=Dubinsky |first4=R.M. |last5=Kaye |first5=J.A. |last6=Gwyther |first6=L. |last7=Mohs |first7=R.C. |last8=Thal |first8=L.J. |last9=Whitehouse |first9=P.J. |last10=DeKosky |first10=S.T. |last11=Cummings |first11=J.L. |date=2001-05-08 |title=Practice parameter: Management of dementia (an evidence-based review) [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology |journal=Neurology |language=en |volume=56 |issue=9 |pages=1154–1166 |doi=10.1212/WNL.56.9.1154 |pmid=11342679 |issn=0028-3878|doi-access=free }}
• {{Cite journal |last1=Doody |first1=Rachelle S |last2=Gavrilova |first2=Svetlana I |last3=Sano |first3=Mary |last4=Thomas |first4=Ronald G |last5=Aisen |first5=Paul S |last6=Bachurin |first6=Sergey O |last7=Seely |first7=Lynn |last8=Hung |first8=David |date=2008 |title=Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study |url=https://linkinghub.elsevier.com/retrieve/pii/S0140673608610740 |journal=The Lancet |language=en |volume=372 |issue=9634 |pages=207–215 |doi=10.1016/S0140-6736(08)61074-0|pmid=18640457 |s2cid=205951657 }}
• {{Cite journal |last1=Doody |first1=Rachelle S. |last2=Thomas |first2=Ronald G. |last3=Farlow |first3=Martin |last4=Iwatsubo |first4=Takeshi |last5=Vellas |first5=Bruno |last6=Joffe |first6=Steven |last7=Kieburtz |first7=Karl |last8=Raman |first8=Rema |last9=Sun |first9=Xiaoying |last10=Aisen |first10=Paul S. |last11=Siemers |first11=Eric |last12=Liu-Seifert |first12=Hong |last13=Mohs |first13=Richard |date=2014-01-23 |title=Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease |journal=New England Journal of Medicine |language=en |volume=370 |issue=4 |pages=311–321 |doi=10.1056/NEJMoa1312889 |pmid=24450890 |issn=0028-4793|doi-access=free }}

Doody received a Distinguished Alumni Award from Rice University in 2009 and a Distinguished Faculty Award from Baylor College of Medicine in 2011. In 2018 she received a Lifetime Achievement Award from the Clinical Trials in Alzheimer’s Disease Society.{{cite web |title=Rachelle Doody Biography |url=https://www.horizons.health/speaker/rachelle-doody-md-phd |website=horizons.health}}{{Better source needed|reason=The current source is insufficiently reliable (WP:NOTRS).|date=September 2022}}

{{reflist}}

{{Authority control}}

{{DEFAULTSORT:Doody, Rachelle}}

Category:Living people

Category:American neurologists

Category:Rice University alumni

Category:Baylor College of Medicine alumni

Category:Baylor College of Medicine faculty

Category:Baylor College of Medicine physicians and researchers

Category:Alzheimer's disease researchers

Category:American women medical researchers

Category:Year of birth missing (living people)